Clinical Trial Update: Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating low power laser (low-level light therapy) as prevention of oral mucositis and oropharyngeal pain in patients undergoing allogeneic he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation
• Stomatitis

Drugs mentioned

• Low-level Light Therapy

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Hematopoietic Stem Cell Transplantation, Low-Level Light Therapy | Phase 3 | Status: RECRUITING